Clinical trial
Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid…
NCT00471562 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00471562 |
|---|---|
| Title | Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid Tumors |
| Official title | Phase I Clinical Trial of Angiotensin 1-7 for Advanced Solid Tumors |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological |
| Interventions | therapeutic angiotensin-(1-7) |
| Enrollment | 18 |
| Start date | Mar 1, 2007 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | May 10, 2007 |
| Last update posted | Aug 1, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: